Prakiraan wutah bathi resik saben saham kanggo taun ngarep NuCana Corp (NCNA)

Logo korporat perusahaan NuCana (NCNA)

NuCana plc relies on external contractors for formula synthesis and clinical trials. EPS growth prospects for the next fiscal year visualize this process, where the parameter mark equals 0.00. This drives the development of the ProTide platform to combat biliary tract cancer, while patent protection enables the company to successfully withstand competition in the resistant tumor segment.

NuCana Corp (NCNA): Prakiraan wutah bathi resik saben saham kanggo taun ngarep saka 04.07.2022 nganti 17.11.2026

Ringkesan rincian data analitis NuCana plc (NCNA)

- rega saham lan konsensus proyeksi valuasi:
Analisis fundamental perusahaan:NuCana PLC
Produk dadi NuCana Corp

This indicator measures the weighted average analyst expectation regarding earnings per share growth rates, as reflected in analyst valuations of net income dynamics for year n+1. For NuCana (NCNA), which is currently in the clinical trial stage without commercial sales, this forecast is based not on current FCF, but on the probability of successful R&D completion and the future capitalization of its drug pipeline.

Analisis pesaing NuCana plc

INCY (incyte.com) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep hutch-med.com HCM|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Nuvation Corp (NUVB)|DAWN - Prakiraan wutah bathi resik saben saham ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Monopar Pharma MNPR|Inhibrx Corp - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|IMAB - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Fennec Pharmaceuticals|HRTX: Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep Nuvectis NVCT|Prakiraan wutah bathi saben saham kanggo taun ngarep CHRS|Prakiraan wutah bathi resik saben saham ing taun ngarep Corbus Pharmaceuticals CRBP|Prakiraan wutah bathi saben saham kanggo taun ngarep CRDF (Cardiff Oncology Inc.)|BYSI (BeyondSpring) - Dinamika bathi saben saham sing diarepake ing taun ngarep|BioAtla - Prakiraan wutah bathi saben saham kanggo taun ngarep|Proyeksi tambahing bathi saben saham ing taun ngarep LIXT (Lixte Biotechnology Holdings, Inc.)|Citius Pharmaceuticals, Inc. - Prakiraan wutah bathi kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep CLRB (Cellectar)|BLRX: Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep canfite.com (CANF)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep aprea.com|KZIA: Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep SLXN|Prakiraan wutah bathi kanggo taun ngarep Chimerix Inc (CMRX)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Cyclacel Pharmaceuticals Inc. CYCC|GTHX (g1therapeutics.com) - Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep|KRON: Prakiraan wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Kintara Therapeutics Inc|oncternal.com (ONCT) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep PRTG (Portage Biotech Corp)